Department of Management and Logistics in Health Care, Medical University of Lodz, 90-237 Lodz, Poland.
Narvik Campus, Tromsø School of Business and Economics, University of Tromsø, 8505 Narvik, Norway.
Int J Environ Res Public Health. 2021 Aug 28;18(17):9103. doi: 10.3390/ijerph18179103.
This article presents an overview of contemporary risk assessment systems used in patients with myocardial infarction. The full range of risk scales, both recommended by the European Society of Cardiology and others published in recent years, is presented. Scales for assessing the risk of ischemia/death as well as for assessing the risk of bleeding are presented. A separate section is devoted to systems assessing the integrated risk associated with both ischemia and bleeding. In the first part of the work, each of the risk scales is described in detail, including the clinical trials/registers on the basis of which they were created, the statistical methods used to develop them, as well as the specification of their individual parameters. The next chapter presents the practical application of a given scale in the patient risk assessment process, the timing of its application on the timeline of myocardial infarction, as well as a critical assessment of its potential advantages and limitations. The last part of the work is devoted to the presentation of potential directions for the development of risk assessment systems in the future.
本文概述了目前用于心肌梗死患者的风险评估系统。本文呈现了全套风险评分系统,包括欧洲心脏病学会推荐的和近年来发表的其他评分系统。介绍了用于评估缺血/死亡风险以及出血风险的评分系统。还有一个单独的部分专门用于评估与缺血和出血相关的综合风险的系统。在工作的第一部分,详细描述了每种风险评分系统,包括创建它们的临床试验/注册、用于开发它们的统计方法以及其各个参数的规范。下一章介绍了在患者风险评估过程中应用特定评分系统的实际情况,应用的时间点以及对其潜在优缺点的批判性评估。工作的最后一部分致力于介绍未来风险评估系统发展的潜在方向。